drugset / Trial / NCT07639021
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Timeline
- Start
- 2026-06-09
- Primary completion
- 2027-06-14
- Completion
- 2027-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NNC0662-0419 | Unknown | — | Subcutaneous |
| Subject | Semaglutide | Peptide | — | Subcutaneous |